|

CBI-1214 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Cartography Biosciences1

Indications

  • Colorectal (Colon or Rectal) Cancer1
  • Metastatic Colon Cancer1
  • CRC1
  • Colorectal Cancer (CRC)1
  • Colon Cancer1

Los Angeles, California1 trial

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

Valkyrie Clinical Trials

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.